Loading institutional data...
Loading institutional data...
Held by 172 of 5,944 reporting institutions (90th percentile) — extremely crowded.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $4.60 today, the market must believe free cash flow compounds -17.4%/yr for a decade (off $59M normalized FCF).
The market's -17.4% is more conservative than its 9-yr track record.
2-stage DCF · 0.05B shares · net debt -$14M
mean 2.7% · volatility σ 74% · implied rate exceeded in 5/9 yrs
Central path = implied -17.4%/yr growth; shaded band = ±1σ (74%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Eight indices comparing this year to last (receivables, margins, asset quality, growth, accruals, leverage). Above −1.78 suggests possible manipulation; below −2.22 is clean.
A screen, not proof — high growth alone can raise it.
Cash conversion lags reported earnings — watch accruals. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor; leverage rising year-over-year.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
The dividend is comfortably covered — only 26% of free cash flow, leaving room to grow it and fund buybacks. Last year: $12M dividends + $20M buybacks = $32M returned on $46M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 10 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: 16%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 10 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Cash of $239M covers all $225M of scheduled principal — no refinancing pressure. Scheduled principal only (excludes interest & revolver draws). As of 2025-12-31 (10-K).
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Coverage is adequate but not comfortable. Effective rate ~6.2% on $224M of debt.
Cash of $239M fully covers short-term debt of $20M.
Mostly long-term debt (balance-sheet current vs non-current split). See the maturity ladder above for the year-by-year repayment schedule.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Maturity ladder from the SEC long-term-debt repayment schedule. Educational — not a recommendation.
EOD close · as of 2026-09-17
Nothing notable to watch.
Where each multiple sits in its own 14-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 14-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Returns are margin-driven, not leverage-driven — higher quality.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 10.1× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2018 | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|---|
| Cost of Revenue | 23.7 | 24.0 | 25.5 | 25.0 | 28.3 | 31.1 | 31.8 | 30.6 |
| Gross Profit | 76.3 | 76.0 | 74.5 | 75.0 | 71.7 | 68.9 | 68.2 | 69.4 |
| R&D | 0.9 | 1.2 | 0.9 | 1.0 | 1.0 | 1.1 | 0.8 | 0.7 |
| SG&A | 24.7 | 25.4 | 24.7 | 24.3 | 25.0 | 27.8 | 27.7 | 29.1 |
| Operating Income | 9.0 | 11.0 | 10.0 | 8.7 | 5.0 | 2.5 | -8.8 | 4.4 |
| Income Tax | 3.6 | 3.4 | 2.5 | 3.2 | -0.7 | 0.9 | -1.6 | 2.4 |
| Net Income | 4.5 | 7.2 | 7.4 | 5.5 | 4.7 | 0.4 | -8.5 | 10.8 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on NUS: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
EOD close · as of 2026-09-17
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $1.49B 100.0% | $1.73B 100.0% | $1.97B 100.0% | $2.23B 100.0% | $2.70B 100.0% | $2.58B 100.0% | $2.42B 100.0% | $2.68B 100.0% | $2.28B 100.0% | $2.21B 100.0% |
| Cost of Revenue | $453.8M 30.6% | $550.2M 31.8% | $611.9M 31.1% | $630.9M 28.3% | $675.2M 25.0% | $658.0M 25.5% | $581.4M 24.0% | $634.1M 23.7% | $502.1M 22.0% | $500.5M 22.7% |
| Cost of Products | — | — | — | — | — | — | — | — | $502.1M 22.0% | $500.5M 22.7% |
| Gross Profit | $1.03B 69.4% | $1.18B 68.2% | $1.36B 68.9% | $1.59B 71.7% | $2.02B 75.0% | $1.92B 74.5% | $1.84B 76.0% | $2.04B 76.3% | $1.78B 78.0% | $1.71B 77.3% |
| Research & Development | $10.8M 0.7% | $13.0M 0.8% | $22.6M 1.1% | $23.3M 1.0% | $27.2M 1.0% | $23.3M 0.9% | $30.1M 1.2% | $23.0M 0.9% | $22.0M 1.0% | $24.3M 1.1% |
| Selling, General & Admin | $432.1M 29.1% | $479.0M 27.7% | $546.9M 27.8% | $555.8M 25.0% | $654.4M 24.3% | $636.5M 24.7% | $616.0M 25.4% | $662.3M 24.7% | $564.5M 24.8% | $554.2M 25.1% |
| Total Operating Expenses | $965.6M 65.0% | $1.33B 77.0% | $1.31B 66.5% | $1.48B 66.7% | $1.79B 66.3% | $1.67B 64.5% | $1.57B 64.9% | $1.80B 67.3% | $1.50B 65.9% | $1.48B 66.9% |
| Operating Income | $65.8M 4.4% | -$151.6M -8.8% | $48.3M 2.5% | $110.8M 5.0% | $234.0M 8.7% | $257.6M 10.0% | $267.4M 11.0% | $240.9M 9.0% | $274.5M 12.0% | $231.1M 10.5% |
| Interest Expense | $13.9M 0.9% | $26.4M 1.5% | $25.6M 1.3% | $13.5M 0.6% | $11.0M 0.4% | $13.1M 0.5% | $19.2M 0.8% | $21.8M 0.8% | $22.2M 1.0% | $15.6M 0.7% |
| Other Income (Expense), net | -$31.8M -2.1% | $2.9M 0.2% | $3.9M 0.2% | -$8.4M -0.4% | -$1.5M -0.1% | -$1.3M -0.1% | -$12.3M -0.5% | -$21.2M -0.8% | -$8.9M -0.4% | -$18.3M -0.8% |
| Pretax Income | $196.2M 13.2% | -$175.1M -10.1% | $26.6M 1.3% | $89.0M 4.0% | $232.5M 8.6% | $256.2M 9.9% | $255.2M 10.5% | $219.7M 8.2% | $265.6M 11.7% | $212.8M 9.6% |
| Income Tax Expense | $36.0M 2.4% | -$28.5M -1.6% | $18.0M 0.9% | -$15.8M -0.7% | $85.2M 3.2% | $64.9M 2.5% | $81.6M 3.4% | $97.8M 3.6% | $136.1M 6.0% | $69.8M 3.2% |
| Net Income | $160.2M 10.8% | -$146.6M -8.5% | $8.6M 0.4% | $104.8M 4.7% | $147.3M 5.5% | $191.4M 7.4% | $173.6M 7.2% | $121.9M 4.5% | $129.4M 5.7% | $143.1M 6.5% |
| Per Share | ||||||||||
| EPS (Basic) | $3.25 | $-2.95 | $0.17 | $2.10 | $2.93 | $3.66 | $3.13 | $2.21 | $2.45 | $2.58 |
| EPS (Diluted) | $3.18 | $-2.95 | $0.17 | $2.07 | $2.86 | $3.63 | $3.10 | $2.16 | $2.36 | $2.55 |
| Weighted Avg Shares (Basic) | 49.3M | 49.7M | 49.7M | 50.0M | 50.2M | 52.3M | 55.5M | 55.2M | 52.8M | 55.4M |
| Weighted Avg Shares (Diluted) | 50.3M | 49.7M | 49.9M | 50.5M | 51.4M | 52.8M | 55.9M | 56.5M | 54.9M | 56.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Ranked against 229 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $852.5B | 39.1× | — | 1.2× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $396.2B | 49.1× | 30.3× | 1.4× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.5× | 4,050 |
| KO | $378.9B | 29.0× | 24.9× | 7.9× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $346.8B | 22.7× | 16.4× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $296.4B | 26.2× | 17.3× | 7.3× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $183.0B | 22.3× | 14.9× | 1.9× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| MO | $116.7B | 16.9× | 13.6× | 5.0× | -3.1% | 62.5% | 29.8% | -198% | 31.3% | 2.5× | 2,375 |
| MDLZ | $80.3B | 32.8× | 18.9× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| TGT | $72.4B | 19.7× | 10.5× | 0.7× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| CL | $70.3B | 33.4× | 19.6× | 3.5× | 1.4% | 60.1% | 10.5% | 3948% | 26.5% | 2.0× | 1,873 |
| MNST | $43.5B | — | 16.4× | 5.3× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| KDP | $42.7B | 20.5× | 14.3× | 2.6× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| ADM | $42.6B | 39.5× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| FMX | $41.0B | — | — | — | — | — | — | — | — | — | 290 |
| JBS | $39.7B | — | — | — | — | — | — | — | — | — | 241 |
| KR | $39.6B | 39.5× | 10.0× | 0.3× | 0.4% | — | 0.7% | 17.1% | 4.7% | 3.0× | 1,327 |
| SYY | $38.6B | 21.2× | 9.7× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $34.2B | 23.5× | 11.7× | 2.3× | -2.1% | 58.1% | 9.7% | 13.7% | 12.0% | 0.5× | 967 |
| HSY | $34.1B | — | 20.1× | 2.9× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| EL | $33.8B | — | 768.2× | 2.4× | -8.2% | 74.0% | -7.9% | -29.3% | -29.3% | 0.1× | 800 |
| KMB | $32.6B | 16.2× | 10.3× | 2.0× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KHC | $29.3B | — | — | 1.2× | -3.5% | 33.3% | -23.4% | -14.0% | -14.0% | — | 1,059 |
| DG | $27.5B | 18.2× | 8.1× | 0.6× | 5.2% | 30.7% | 3.5% | 17.8% | 17.8% | — | 1,099 |
| KOF | $23.6B | — | — | — | — | — | — | — | — | — | 249 |
| CHD | $23.1B | 31.5× | 18.8× | 3.7× | 1.6% | 44.7% | 11.9% | 18.4% | 11.9% | 1.7× | 1,004 |
| NUS | $227M | 1.4× | 1.8× | 0.1× | -14.3% | 69.4% | 10.8% | 19.9% | 15.6% | 1.9× | 172 |
Peers = companies sharing NUS's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.